Table 3 :
Table 3 describes the maintenance dose ranges obtained at the end of the initial titration period, which are classified as low (200-400 μg twice daily) medium (600– 1,000 μg twice daily) and high (1,200–1,600 μg twice daily). Low, nedium and high dose definitions are derived from the GRIPHON Study protocol.